| RS1645575465 |
CDC42
|
Health Risk |
Conflicting classifications of pathogenicity |
Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome, CDC42-related disorder |
| RS1645586485 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1645607563 |
DOCK7
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS1645656856 |
DOCK7
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS1645663483 |
CDC42
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome, Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome |
| RS1645686564 |
PLOD1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS1645691337 |
PLOD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS1645806893 |
RPE65
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 2, RPE65-related recessive retinopathy |
| RS1645822647 |
RPE65
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1645823028 |
RPE65
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 2, Retinitis pigmentosa 20 |
| RS1645823354 |
RPE65
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 20, Leber congenital amaurosis 2 |
| RS1645824187 |
RPE65
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Leber congenital amaurosis 2 |
| RS1645824260 |
RPE65
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1645826120 |
RPE65
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 2, RPE65-related recessive retinopathy |
| RS1645826941 |
RPE65
|
Health Risk |
Pathogenic |
Autosomal recessive retinitis pigmentosa, RPE65-related recessive retinopathy |
| RS1645848679 |
DNAJC6
|
Health Risk |
Pathogenic |
Juvenile onset Parkinson disease 19A, Juvenile onset Parkinson disease 19A |
| RS1645855563 |
PLOD1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS1645867120 |
DNAJC6
|
Health Risk |
Pathogenic |
Juvenile onset Parkinson disease 19A, Juvenile onset Parkinson disease 19A |
| RS1645875407 |
RPE65
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 2, Retinitis pigmentosa 20 |
| RS1645879495 |
RPE65
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 2, Retinitis pigmentosa 20 |
| RS1645879569 |
RPE65
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 2, Autosomal recessive retinitis pigmentosa |
| RS1645880232 |
RPE65
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 2, Leber congenital amaurosis 2 |
| RS1645880293 |
RPE65
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 2, Leber congenital amaurosis 2 |
| RS1645882103 |
RPE65
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 2, Leber congenital amaurosis 2 |
| RS1645882447 |
RPE65
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 20, Leber congenital amaurosis 2 |
| RS1645883131 |
RPE65
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 2, RPE65-related recessive retinopathy |
| RS1645885777 |
RPE65
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 20, Leber congenital amaurosis 2 |
| RS1645885900 |
RPE65
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 2, Retinitis pigmentosa 20 |
| RS1645896934 |
RPE65
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 20, Leber congenital amaurosis 2 |
| RS1645898265 |
RPE65
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 20, Leber congenital amaurosis 2 |
| RS1645898413 |
RPE65
|
Health Risk |
Likely pathogenic |
Autosomal recessive retinitis pigmentosa, RPE65-related recessive retinopathy |
| RS1645898563 |
RPE65
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 2, Retinitis pigmentosa 20 |
| RS1645927790 |
RPE65
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 2, RPE65-related recessive retinopathy |
| RS1645928251 |
RPE65
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 2, Leber congenital amaurosis 2 |
| RS1645928294 |
RPE65
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 2, Retinitis pigmentosa 20 |
| RS1645929674 |
RPE65
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 2, Retinitis pigmentosa 20 |
| RS1645945363 |
RPE65
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis, Retinitis pigmentosa 20 |
| RS1645945392 |
RPE65
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 2, Retinal dystrophy |
| RS1645945582 |
RPE65
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 2, Leber congenital amaurosis 2 |
| RS1645945599 |
RPE65
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 2, RPE65-related recessive retinopathy |
| RS1645945643 |
RPE65
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 2, Leber congenital amaurosis 2 |
| RS1645945978 |
RPE65
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 20, Leber congenital amaurosis 2 |
| RS1645959896 |
RPE65
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 2, Retinitis pigmentosa 20 |
| RS1646006817 |
DOCK7
|
Health Risk |
Likely pathogenic |
— |
| RS1646008860 |
RERE
|
Health Risk |
Likely pathogenic |
— |
| RS1646080085 |
MTOR
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1646236200 |
DOCK7
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS1646253231 |
NFIA
|
Health Risk |
Pathogenic |
Chromosome 1p32-p31 deletion syndrome, Chromosome 1p32-p31 deletion syndrome |
| RS1646254633 |
NFIA
|
Health Risk |
Pathogenic |
Chromosome 1p32-p31 deletion syndrome, Chromosome 1p32-p31 deletion syndrome |
| RS1646255018 |
NFIA
|
Health Risk |
Likely pathogenic |
— |
| RS1646257371 |
NFIA
|
Health Risk |
Pathogenic/Likely pathogenic |
Chromosome 1p32-p31 deletion syndrome, Chromosome 1p32-p31 deletion syndrome |
| RS1646260006 |
NFIA
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1646342863 |
MTOR
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1646379664 |
DOCK7
|
Health Risk |
Pathogenic |
— |
| RS1646420881 |
GNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1646448461 |
GNB1
|
Health Risk |
Likely pathogenic |
— |
| RS1646670079 |
GNB1
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS1646670170 |
GNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, See cases |
| RS1646670990 |
GNB1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 42 |
| RS1646696544 |
GNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 42 |
| RS1646697327 |
GNB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 42 |
| RS1646718218 |
YRDC
|
Health Risk |
Pathogenic |
Galloway-Mowat syndrome 10, Galloway-Mowat syndrome 10 |
| RS1646752498 |
YRDC
|
Health Risk |
Pathogenic |
Galloway-Mowat syndrome 10, Galloway-Mowat syndrome 10 |
| RS1646757490 |
PTEN
|
Health Risk |
Pathogenic |
PTEN hamartoma tumor syndrome, PTEN hamartoma tumor syndrome |
| RS1646774558 |
DAB1
|
Health Risk |
Likely pathogenic |
Spastic ataxia, Spastic ataxia |
| RS1646822375 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1646830386 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1646883385 |
FOXE3
|
Health Risk |
Likely pathogenic |
Congenital primary aphakia, Anterior segment dysgenesis |
| RS1646884829 |
FOXE3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Congenital primary aphakia |
| RS1646884931 |
FOXE3
|
Health Risk |
Likely pathogenic |
Congenital primary aphakia, Congenital primary aphakia |
| RS1646962392 |
DHCR24
|
Health Risk |
Likely pathogenic |
Desmosterolosis, Desmosterolosis |
| RS1647004958 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS1647009785 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS1647010155 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS1647014461 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS1647014537 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS1647016174 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS1647019292 |
MPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS1647019645 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS1647019692 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS1647020172 |
MPL
|
Health Risk |
Pathogenic |
Essential thrombocythemia, Congenital amegakaryocytic thrombocytopenia |
| RS1647020318 |
MPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS1647021342 |
ACADM
|
Health Risk |
Pathogenic/Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1647022933 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS1647023010 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS1647053042 |
TOE1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1647059319 |
MPL
|
Health Risk |
Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia |
| RS1647059649 |
MPL
|
Health Risk |
Pathogenic |
Essential thrombocythemia, Congenital amegakaryocytic thrombocytopenia |
| RS1647060064 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS1647073222 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS1647074009 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS1647077635 |
MPL
|
Health Risk |
Pathogenic |
Essential thrombocythemia, Congenital amegakaryocytic thrombocytopenia |
| RS1647090485 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1647100516 |
MPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS1647138135 |
ORC1
|
Health Risk |
Likely pathogenic |
— |
| RS1647148516 |
NPHP4
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1647165465 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1647169738 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1647169888 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1647180436 |
KCNQ4
|
Health Risk |
Pathogenic |
— |